Tdoc stock forecast metrics anticipate gradual valuation

TDOC stock forecast metrics anticipate gradual valuation improvement, with discounted cash flow models showing fair value closer to $ Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Teladoc Health analysts - going out to 2027, and you can see them free on our platform here. Shares of digital medical services platform Teladoc Health TDOC jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential following Teladoc's impressive updates at a Goldman Sachs Healthcare conference. Latest TDOC stock forecast revisions reflect stable patient retention rates above industry average, providing baseline revenue security. Index performance comparisons show TDOC tracking slightly above healthcare sector ETF in recent sessions.